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Abstract.  Ligand binding to the membrane receptor 
for EGF induces its clustering and internalization. 
Both receptor and ligand are then degraded by 
iysosomai enzymes. A  kinase defective point mutant 
(K721A) of EGF receptor undergoes internalization 
similarly to the wild-type receptor.  However, while in- 
ternalized EGF molecules bound to either the wild-. 
type or mutant receptors are degraded, the K721A 
mutant receptor molecules recycle to the cell surface 
for reutilization. To investigate the mechanism of 
receptor trafficking, we have established transfected 
NIH-3T3  cells coexpressing the kinase-negative mutant 
(K721A) together with a  mutant EGF receptor (CD63) 
with active kinase. CD63  was chosen because it be- 
haves like wild-type EGF receptor with respect to bio- 
logical responsiveness and cellular routing but afforded 
immunological distinction between kinase active and 
inactive mutants. Although expressed in the same 
cells, the two receptor mutants followed their separate 
endocytic itineraries. Like wild-type receptor, the CD63 
mutant was downregulated and degraded in response 
to EGF while the kinase-negative mutant K721A 
returned to the cell surface for reutilization. Intracellu- 
lar trafficking of EGF receptor must be determined by 
a  sorting mechanism that specifically recognizes EGF 
receptor molecules according to their intrinsic kinase 
activity. 
T 
HE growth stimulatory signal of EGF is mediated by 
the EGF receptor (EGFR),t a  170-kD transmembrane 
glycoprotein with intrinsic protein tyrosine kinase ac- 
tivity (for reviews, see references 1, 19, 23). Ligand binding 
to the extracellular domain of EGFR leads to receptor oligo- 
merization, which plays a crucial role in the activation of the 
cytoplasmic protein tyrosine kinase (for reviews,  see refer- 
ences 19, 20). This leads to autophosphorylation of tyrosine 
residues within the carboxy terminus of EGFR and the phos- 
phorylation of a  variety of cellular substrate proteins (for 
reviews, see references 14, 15, 25). The kinase activity of the 
receptor is  indispensable for Signal transfunction. Mutant 
receptors with inactive kinase are unable to elicit any of the 
effects associated with EGF-stimulated mitogenesis. These 
include EGF-induced increases in intracellular pH and free 
Ca  2÷ concentration, stimulation of glucose and amino acid 
transport, phosphoinositol turnover, c-myc and c-fos expres- 
sion, DNA synthesis, and cell transformation (2,  8, 9,  16, 
18). Besides ligand activation, a variety of intrinsic and ex- 
ternal mechanisms modulate the activity of the EGFR kinase 
(19). The intrinsic autophosphorylation sites of EGFR pro- 
vide a  control mechanism by competing with endogenous 
substrates for the active site, thus buffering receptor activity 
1. Abbreviations used in this paper: DHFR, dihydrofolate reductase; EDAC, 
1-Ethyl-3-(3-dimethylaminopropyl)  carbodiimide; EGFR, epidermal growth 
factor receptor. 
by increasing the activation threshold for biological response 
(10, 11, 22). Binding of EGF induces a negative feedback re- 
sponse by stimulating receptor internalization and degrada- 
tion (6, 7, 21). An EGFR point mutant (K721A) with inactive 
kinase undergoes ligand-induced internalization, but fails to 
be downregulated. Unlike wild-type receptors that are de- 
graded after internalization, the kinase-defective mutant re- 
cycles to the cell surface for reutilization (8). 
To study the mechanisms regulating receptor trafficking 
after ligand stimulated internalization, we have established 
transfected cells that coexpress kinase negative receptor mu- 
tant together with EGFR bearing an active, ligand-regulated 
tyrosine kinase. Detailed analysis of ligand internalization, 
surface receptor downregulation, and degradation of these 
two receptor species coexpressed at different ratios in the 
same cell indicated that the kinase defective mutant and the 
active EGFR follow separate endocytic pathways even when 
expressed in the same cells. 
Materials and Methods 
Transfection 
NIH 3T3 cells (clone 2.2), lacking endogenous EGFR (8) were grown in 
DME (Gibco Laboratories, Grand Island, NY) with 10% FCS. Cells grown 
in 10-cm dishes were transfected with 10-20/zg of plasmid DNA per dish 
using the calcium phosphate precipitation technique (24). The plasmid con- 
tained dihydrofolate reductase (DHFR) and neomycin resistance genes as 
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added to the medium to select for neomycin resistant transfectants. Clones 
were picked after 3 wk and characterized. 
Cell line K72 IA (clone 19) is a primary NIH-3T3 transfectant expressing 
",,300,000 kinase-negative (K721A) receptors per cell (8). This cell line was 
used as parental line for second transfection with an expression plasmid en- 
coding the EGFR mutant CD63, which lacks 63 carboxy-terminal amino 
acids (17). As a control, the same construct was also transfected into paren- 
tal NIH-3T3 cells. Plasmid pSVgtp was cotransfected at l0 times lower con- 
centration than the plasmid encoding the receptor mutant to provide guano- 
sine phosphoribosyl transferase as selectable marker. The transfected cells 
were grown in a selection medium composed of DME with 10% calf serum, 
1%  penicillin/streptomycin,  1%  glutamine supplemented with 40 #g/ml 
mycopbenolic acid,  5  /~M  aminopterine,  10  #g/ml  thymidine,  100  p.M 
hypoxanthine, 250 #g/ml xanthine, and l0 #g/ml glycine. Individual colo- 
nies were  isolated and the clones characterized by  immunoprecipitation 
with anti-EGFR antibodies, SDS-PAGE,  and immunoblotting. 
lodination of EGF 
Murine EGF (Toyobu, Tokyo, Japan) was iodinated to a specific activity of 
100,000 cpm/ng using the Chloramin-T method and separated from free io- 
dide by gel filtration. 
J2q-EGF Internalization and EGF 
Receptor Downregulation 
Ceils were seeded at a density of 100,000 cells/well in fibronectin-coated 
24-well dishes. After 2 d, the cells were washed and incubated with 1,  10, 
or  100 ng/ml, t2SI-EGF  in DME containing 2%  BSA and 50 mM Hepes 
pH 7.5 were cooled for 90 rain on ice. The cells were rapidly warmed to 
37°C and incubated at this temperature for various times. The cells were 
washed three times with PBS, and surface-associated ligand collected by 
two washes with ice-cold 0.5 M acetic acid containing 150 mM NaC1. The 
radioactive content of internalized 125I-EGF was determined after solubili- 
zation of the cells with 1 N NaOH for 30 rain at 37°C. To compare the rela- 
tive contributions of surface bound versus internalized EGF in different cell 
lines, the curves were expressed as a percent of total cell associated radioac- 
tivity after 90 rain incubation on ice (t  =  0). 
Scatchard Analysis of'2~I-EGF  Binding Data 
Cells were plated at a density of 100,000 cells/well in fibronectin-coated 24- 
well dishes. 2 d later, the cells were incubated for 2 h at 37°C with 50 ng/ml 
EGF  in DME with 0.5%  FCS in 25  mM Hepes pH 7.5.  The cells were 
washed twice with PBS and incubated in DME, 0.5% FCS, 25 nM Hepes 
without any added EGF for 30 rain at 37°C to dissociate or internalize resid- 
ual unlabeled EGE  After an additional wash with PBS the cells were in- 
cubated with t25I-EGF  in DME, 50 mM Hepes, 2 mg/ml BSA for 60 min 
at  room  temperature.  After  washing and  solubilization  the  lysate  was 
counted in a gamma counter to determine the total amount of ligand bound 
to the cells. The results were presented in the form of Scatchard curves and 
fitted by a model for either one or two binding sites to calculate the apparent 
affinity and number of binding sites. 
Chemical Covalent Cross-linking Experiments 
Cells were grown to confluence in fibronectin-coated  10-cm dishes. The 
cells were washed three times with PBS and incubated with PBS containing 
0 or 500 ng/ml EGF and 15 mM of the chemical cross-linking agent l-Ethyl- 
3(3-dimethylaminopropyl) carbodiimide EDAC for either  15 min at 37°C 
or for 60 rain at room temperature. Cells were washed two times with PBS 
and incubated for 5 min with 150 mM glycine in PBS to block excess cross- 
linker.  After solubilization and immunoprecipitation with either RK2 or 
anti-C antibodies bound to protein A-Sepharose, the samples were either 
autophosphorylated with [.-t3ZP]ATP  or analyzed by SDS-PAGE and immu- 
noblotting. 
Receptor Downregulation and Degradation 
Cells were grown to confluence in fibronectin-coated 10-cm dishes. They 
were washed and starved overnight in DME containing 0.5%  FCS.  500 
ng/ml EGF were added to each dish, and after different times up to 8 h, 
the cells were lysed in 0.5 ml of lysis buffer per plate (lysis buffer: 50 mM 
Hepes  pH  7.5,  150  mM  NaCI,  l  mM  EGTA,  1.5  mM  MgCI2,  10% 
glycerol,  1% Triton X-100; protease inhibitors: 4/~g/ml PMSF,  10 ~g/ml 
leupeptin,  10 ~g/ml aprotinin) and the lysates frozen at  -70°C. The EGF 
receptor was immunoprecipitated from the lysates with protein A-Sepha- 
rose-bound RK2 antibodies, which recognize all mutant receptors described 
in this report. After washing with HNTG (25 mM Hepes pH 7.5,  150 mM 
NaCI, 0.1% Triton X-100, and 10% glycerol) two equal samples were ana- 
lyzed by SDS-PAGE and transferred to nitrocellulose. One of the blots was 
analyzed with anti-C antibodies (which recognize wt and K72 IA), the other 
with RK2 antibodies. After incubation with  t2Sl-protein  A, the two blots 
were autoradiographed. Radioactive bands were cut out and quantitated in 
a "r-counter. 
Determination of  Receptor Half-Lives 
Cells were grown in fibronectin-coated 10-cm dishes and labeled overnight 
with  [35S]methionine in DME containing 0.5%  dialyzed FCS.  The cells 
were washed to remove excess methionine and chased in complete medium 
containing 500 ng/ml EGE After different chase times, the cells were lysed 
and the EGFR immunoprecipitated with either protein A-Sepharose-mAbi08 
complex (monoclonal antibody against the extraeellular domain of the EGF 
receptor)  or with protein A-Sepharose anti-C antibodies.  The immuao- 
precipitates were washed and analyzed by SDS-PAGE. The fixed gels soaked 
in ENHANCE  s (Amersham Corp., Arlington Heights, IL) were dried and 
autoradiographed to detect [3SS]methionine-labeled  protein bands. For quan- 
titation of labeled EGFR,  the densities of the bands were measured with 
a densitometric scanner and their integrals compared. 
Results 
We  have  generated  NIH-3T3  cells  expressing  vet  EGFR 
(HER), kinase-negative mutant (K721A), and COOH-termi- 
nally truncated  EGFR (CD63) as well as cells coexpressing 
K721A and CD63 (K721A/CD63 cells). The covalent cross- 
linking agent EDAC was used to demonstrate that EGF bind- 
ing induces rapid oligomerization of EGFR in vitro and in 
living  cells  (3).  Transfected  cells expressing  either  wt or 
K721A  mutant  were  incubated  with  the  covalent  cross- 
linking agent EDAC in the absence or presence of EGE Nei- 
ther receptor showed dimer formation in the absence of EGF 
(Fig.  1, A and B). At room temperature  wt and K721A mu- 
tant were cross-linked with similar efficiency. At 37°C, how- 
ever, cross-linking of K72 IA was impaired, unless internali- 
zation  was  blocked  by  pretreating  the  cells  with  10  mM 
phenylarsine oxide (PAO) for 15 rain at 37°C. At 37°C, both 
wt and K721A receptor are rapidly  internalized upon ligand 
stimulation. While wt and CD63 remain in endocytic compart- 
ment, kinase-negative mutants  are stripped  of their ligands, 
recycled to the cells' surface and redispersed. This process 
is fast compared with the cross-linking reaction at 370C but 
long enough  to enable quantitative  cross-linking  at 230C. 
This explains the reduced cross-linking efficiency of K721A 
under conditions that permit normal receptor trafficking. -We 
have previously demonstrated that EGF-stimulated receptor 
oligomerization in vitro allowed the coimmunopreeipitation 
of CD63 along with K721A when antibodies against carboxy 
terminus (anti-C) were used for the immunoprecipitation  (12). 
The formation of hetero-oligomers of the two mutants in liv- 
ing cells was confirmed by using  a covalent cross-linking 
agent. EGF was added to K721A/DC63 cells, and after incu- 
bation  with the cross-linking  agent  EDAC, the cells were 
washed, lysed, and the EGFR immunoprecipitated with anti- 
C  antibodies (which recognize K721A but not CD63)  and 
analyzed by SDS-PAGE and autoradiography.  As shown in 
Fig. 1, EGF induced the formation of receptor dimers. More- 
over, the fact that kinase activity can be detected in the im- 
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ing in intact cells. Control un- 
transfected cells (NIH). Cells 
expressing  wt EGFR (HER), 
a COOH-terminally  truncated 
active mutant (CD63), kinase- 
negative receptor (K721A), and 
cells coexpressing  CD63  and 
K721A were treated  with the 
covalent crosslinker EDAC (3) 
in the presence or absence of 
EGF (500 ng/ml). Monomeric 
EGF receptor and cross-linked 
products were immunoprecip- 
itated and separated  by SDS- 
PAGE. For detection, the  re- 
ceptor was either allowed to 
au.tophosphorylate  in  the 
presence of ['y32p]ATP  before 
electrophoresis  or was immu- 
noblotted and labeled with ~I- 
protein A. (A and B) HER and 
K721A  cells were  incubated 
for 15 min at 20°C (A) or for 
60 min at 37°C (B) in the ab- 
sence or presence of 500 ng/ml 
EGF and with  15 nM E  DAC. 
The  cross-linked  receptors 
were immunoprecipitated with 
mAbl08 and  immunoblotted 
with  RK2.  (C and D)  HER, 
K721A,  CD63  and  K721A/ 
CD63 cells were treated for 15 
min at 37°C in the absence or 
presence of 500 ng/ml EGF 
and with  15 mM EDAC. The 
cross-linked  receptors  were 
immunoprecipitated with RK2 
and immunoblotted with RK2 
(C)  or  autophosphorylated 
with  [',/32p]ATP (D).  (E and 
F, next page) HER, CD63 and 
two different clones of K721A/ 
CD63 cells were treated for 15 
rain at 37°C in absence or pres- 
ence of 500 ng/ml EGF and 
with 15 mM EDAC. The cross- 
linked receptors were immuno- 
precipitated with mAbl08 (E) 
or anti-C (F), then autophos- 
phorylated  with [3,32P]ATE 
munoprecipitate  with anti-C antibodies indicates that hetero- 
dimers of K721A and CD63 were formed. 
Ligand Internalization and Receptor Downregulation 
Cells expressing wt EGFR (HER), COOH-terminal trunca- 
tion mutant (CD63),  or  kinase-negative mutant (K721A) 
were allowed to bind ~25I-EGF for 90 min at 4°C. The cells 
were  warmed to 37°C for various time intervals, and the 
amount of cell surface bound and internalized EGF were 
separately determined. For direct comparison of the rates of 
Honegger et al. Trafficking  of EGFReceptors  1543 Fig.  1 (continued) 
internalization  in  the  different  cell  lines,  all  values  are 
presented as percent of total cell-associated  '2q-EGF radio- 
activity  after  90-min  incubation  at  4°C  (Fig.  2).  When 
probed  at  saturating  ligand  concentration  (>100  ng/ml), 
K721A showed only a small and transient decrease in surface 
ligand binding (data not shown), despite efficient ligand up- 
take. When probed at lower ligand concentration (10 ng/ml), 
the loss of the high affinity component of EGF binding led 
to a small, persistent decrease of ligand binding. Under simi- 
lar  conditions,  wt and  CD63  receptors  almost completely 
disappeared  from  the  cell  surface.  In  cells  coexpressing 
K721A and CD63, an intermediate  level of receptor down- 
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Figure 2.  Ligand internaliza- 
tion and surface receptor down- 
regulation.  Cells  expressing 
wt  EGFR  (HER),  COOH- 
terminally truncated active re- 
ceptor (CD63),  kinase-nega- 
tive  receptor  (K721A), and 
different  clones  coexpressing 
K721A and CD63 were incu- 
bated for 90 min on ice with 10 
ng/ml  125I-EGF, then  warmed 
to 37°C  for different time  in- 
tervals. 125I-EGF  bound to cell 
surface receptors and internal- 
ized ligand were separated by 
an  acid-wash  procedure  and 
quantitated  separately.  To be 
able  to directly compare the 
internalization  and downregu- 
lation curves for different cell 
lines, all values were scaled to 
total  binding  at  (t  =  0)  = 
100%. (A and B) Time course 
of  ligand internalization (A) and 
surface receptor downregula- 
tion (B) for wt (solid lines), CD63 (dashed lines), and K72 IA (dotted lines). (C and D) Time course of ligand internalization  (C) and surface 
receptor downregulation  (D) for wt and K721A (solid lines) and  for five different  clones of K721A/CD63  cells  (dotted lines). 
The Journal of Cell Biology, Volume 110, 1990  1544 Table L EGF Receptor Downregulation by Pretreatment with Unlabeled EGF 
Total receptor number 
Percent 
Mutant EGF receptors  k I  n I  k2  n2  I  n I + n2  downregulation 
HER  -  EGF  14  250,000  0.26  21,000  271,000 
+ EGF  19  59,000  2.6  19,000  78,000  71 
K721A  -  EGF  11  343,000  0.34  16,000  359,000 
+EGF  13  280,000  2.3  14,000  294,000  18 
K721A/CD63  -  EGF  11  318,000  0.17  12,000  330,000 
( 1  : 1)  + EGF  15  200,000  0.09  1,000  201,000  39 
K721A/CD63  -  EGF  9.2  250,000  0.09  8,000  258,000 
(I :4)  + EGF  9.5  197,000  -  0  197,000  24 
CD 63  -EGF  11  540,000  0.53  65,000  605,000 
+ EGF  5. i  85,000  -  0  85,000  86 
CD 63  -EGF  9.8  520,000  0.42  46,000  566,000 
+ EGF  5.2  76,000  -  0  76,000  87 
Binding of '251-EGF to cells pretreated with or without 50 ng/ml EGF for 2 h at 37°C was determined as described in Materials and Methods and in Fig. 3. The 
results were plotted in the form of Scatchard curves,  which were best fitted to a model representing either one or two affinity binding sites to determine number 
(n) and apparent dissociation constants (K ×  10  -9 M) of the binding sites. The values in parentheses for the K721A/CD63 cells are the ratios of the level of ex- 
pression of the two mutant receptors as determined  by immunoblotting analyses. 
regulation was observed, depending on the ratio of expres- 
sion of the two mutants in each of the cell lines tested (Fig. 
2, B and D). To obtain a more quantitative estimate of the 
degree of receptor downregulation in the different cell lines, 
Scatchard plots of '25I-EGF binding to cells preincubated in 
the presence or absence of unlabeled EGF were compared. 
The degree of receptor downregulation observed in this ex- 
periment was consistent with the results of the internaliza- 
tion/downregulation experiment (Table I; Fig. 3). It is note- 
worthy that at room temperature, receptor internalization is 
not completely blocked. Yet, this does not influence the mea- 
surement of the number of binding sites, as this information 
is derived from extrapolation to infinite ligand concentration. 
Receptor Degradation 
Confluent cells were treated for various times with EGF, then 
lysed,  immunoprecipitated,  and  analyzed by  SDS-PAGE. 
After transfer to nitrocellulose, immunoblots were analyzed 
with either RK2 antipeptide antiserum, which recognizes wt, 
CD63 and K721A receptor, or with anti-C antipeptide anti- 
bodies,  which  recognize  wt and  K721A  receptor but  not 
CD63 mutant. The blots were probed with ~25I-protein A to 
visualize EGF receptors by autoradiography. EGF was able 
to stimulate receptor degradation in cells expressing either 
wt receptor or CD63  mutant,  but not in cells expressing 
K721A  mutant  (Fig.  4).  However,  in  K721A/CD63  cells, 
loss of receptor protein was observed when probed with RK- 
2 antiserum,  which detects both mutant receptors, but not 
when probed with anti-C, which detects only the K721A mu- 
tant.  Thus, the two mutant receptors responded differently 
to ligand stimulation, even when expressed in the same cell. 
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Figure 3.  Scatchard  analysis  of t25I-EGF 
binding to cells pretreated with EGE Cells 
expressing wt EGFR (HER in A), COOH- 
terminally truncated receptor (CD63 in B), 
kinase-negative receptor (K721A in C), and 
cells  coexpressing  CD63  and  K721A (D) 
were treated for 2 h at 37°C with or without 
50 ng/ml EGE Excess unlabeled ligand was 
removed and the cells incubated for 60 min 
at  22°C  with  different  concentrations  of 
t2SI-EGE Binding to the cells as a function 
of ligand concentration was represented in 
the form of Scatchard plots and numerically 
fitted by computer models for one- and two- 
affinity receptor binding to obtain receptor 
numbers  and  apparent  dissociation  con- 
stants (listed in Table I). Dotted lines indi- 
cate  binding  of  nSI-EGF  to  cells,  solid 
lines indicate binding to cells after down- 
regulation of EGFR. 
Honegger et al.  Trafficking of EGF Receptors  1545 Figure  4.  EGF-induced receptor  degradation. 
Cells expressing wt EGFR (HER in a),  kinase- 
negative receptor (K721A in b), COOH-terminally 
truncated active receptor (CD63 in c), and cells 
coexpressing K721A and CD63 (d) were treated 
for various time intervals up to 8 h at 37°C in ab- 
sence or presence of 500 ng/ml EGE After lysis 
of the cells, the EGF receptors were immunopre- 
cipitated with RK2 and subjected to SDS-PAGE 
analysis. Blots were then reacted with either anti-C 
(A) or RK2 (B) antibodies followed by reaction 
with ~25I-protein A for visualization by autoradi- 
ography. Radioactive  bands were excised for quan- 
titation in a gamma counter. Band intensities were 
plotted against the incubation time with EGE (C) 
Solid symbols denote samples blotted with RK2, 
open symbols denote samples blotted with anti-C. 
Dashed lines indicate receptors levels in cells in- 
cubated with buffer alone. 
Determination of  Receptor Half-Life 
Cells were pulse-labeled with [35S]methionine, then chased 
in the presence or absence of EGE The immunoprecipitated 
receptors were quantitated as a function of time. As shown 
in Fig.  5, in the absence of EGF, wt and K721A receptors 
had a half-life of 12-15 h. In agreement with previous experi- 
ments (8) EGF decreased the half-life ofwt receptor to '~1 h, 
and the half-life of K721A to 8-10 h. Cells expressing a sin- 
gle receptor species had a  single life-time  for the rate of 
receptor degradation. However,  K721A/CD63 cells showed 
a biphasic degradation profile (Fig.  5). The curves consisted 
of a  short-lived component with a  half-life of ~1  h  and a 
long-lived component with a half-life of 8-12 h. The relative 
contributions of  the two components reflected the expression 
levels of the two receptor mutants in the different cell lines 
tested. Anti-C antibodies immunoprecipitated only the long- 
lived component while RK2 antibodies immunoprecipitated 
both long-lived and short-lived receptor populations. These 
results indicate that both CD63 and K721A retain their char- 
acteristic degradation times even when expressed in the same 
cells. 
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Figure 5.  Biosynthetic half-life of EGFR labeled 
with [35S]methionine. Cells expressing wt EGFR 
(HER),  COOH-terminally  truncated,  active  re- 
ceptor (CD63), kinase-negalive receptor (K721A) 
(A), and cells coexpressing K721A and CD63 in 
different ratios (B-D) were labeled overnight with 
[35S]methionine. Excess  [35S]methionine was re- 
moved and the cells chased for up to 32 h. After 
lysis of the cells, the EGF receptors were immuno- 
precipitated  with mAbl08 and analyzed by SDS- 
PAGE. The receptor bands  were quantitated  by 
densitometric  scanning  of the  autoradiographs, 
and  peak intensities  plotted  against  time.  Solid 
lines,  wt (+EGF),  CD63  (+EGF); broken  line, 
K721A (+EGF); dotted line, wt, CD63, and K721A, 
-EGF from references 10,  11. (e) CD 63, actual 
experimental  values. 
Discussion 
We have generated transfected NIH-3T3 lacking endogenous 
EGFR which coexpress similar amounts of CD63 and K72 IA 
mutants and, as a control, NIH-3T3 cells expressing similar 
amounts of wt, CD63, or K721A alone. We have previously 
demonstrated that kinase activity is dispensable for expres- 
sion of EGFR with normal ligand binding characteristics on 
the cell  surface but indispensable  for signal transduction, 
DNA synthesis, transformation, and normal receptor traffick- 
ing (8). 
Covalent cross-linking experiments with cells expressing wt 
EGFR, CD63 mutant and K721A mutant alone or cells coex- 
pressing both CD63 and K721A indicated that the kinase ac- 
tivity is not  essential  for receptor dimerization.  Moreover, 
heterodimeric complexes of CD63 and K721A were formed 
in CD63/K721A cells in response to EGE The extent of het- 
erodimerization and the dimerization of K721A alone was en- 
hanced by inhibition of endocytosis, probably reflecting the 
rapid divergence of the endocytic pathways of the active and 
kinase-deficient EGF receptor mutants. We have also demon- 
strated that the addition of EGF to cells expressing CD63 and 
K721A led to cross-phosphorylation of K721A both in vitro 
and in living cells (12,  13). Like receptor dimerization, cross- 
phosphorylation was greatly increased at 4°C or in the pres- 
ence of PAO which blocks receptor internalization. It appears 
that conditions that block receptor internalization enhance the 
interactions between receptors by preventing their separation 
in the course of their endocytotic itinerary. The formation of 
heterodimers and cross-phosphorylation of K721A by the ac- 
tive receptor kinase could potentially modulate function and 
intracellular routing of the two receptor species. 
Is  autophosphorylation  of  EGFR  involved  in  receptor 
routing? We have previously examined whether autophos- 
phorylation  plays a  role  in  the  regulation  of intracellular 
trafficking by studying transfected cells that express mutant 
EGFR in which autophosphorylation sites were substituted 
by phenylalanine  (Yl173F,  YlI48F,  Y1068F)  or  were  re- 
moved by COOH-terminal truncations. For example, CD63 
and CD126 mutants lack 2 and 4 autophosphorylation sites, 
respectively. Cell lines expressing these mutants were tested 
for  ligand  internalization,  receptor  downregulation,  and 
ligand-induced receptor degradation (10, 11). We have shown 
that EGFR with altered autophosphorylation sites behaved 
like wt receptor with respect to receptor trafficking. Hence, 
autophosphorytation per se does not provide a "flag" to dis- 
tinguish  between  receptors  targeted  to  the  lysosome and 
receptors destined to return to the cell  surface for reutili- 
zation. 
To further explore the factors that regulate receptor traffick- 
ing, we have generated transfected cells that express K721A 
mutants together with CD63. The CD63 mutant was used in 
this analysis because it behaves like wt receptor with respect 
to  internalization,  downregulation,  and biological respon- 
siveness but allowed an immunological distinction between 
receptor bearing an active kinase and kinase-defective mu- 
tant (K721A). In K721A/CD63 cells, the ratio of the two mu- 
tant  receptors  was  determined  by  immunological  means, 
using anti-C antibodies that recognize all three receptor types. 
Several clones,  each  expressing different amounts of both 
mutant receptors, were selected for further characterization. 
The K721A/CD63 cells bound ligand with similar affinity as 
cells expressing either wt or K721A alone and were respon- 
sive to EGF stimulation and DNA synthesis (12). 
Although the efficiency of ligand internalization by trans- 
fected ceils expressing wt, CD63, K72 IA, and K721A/CD63 
did not differ significantly, surface receptor downregulation 
was less  marked  in  K721A/CD63  cells as compared with 
CD63 cells or cells expressing wt receptors (Figs. 2 and 3). 
Depending on the ratio of the two receptor species, different 
lines of K721A/CD63 showed a behavior intermediate to that 
of CD63 or K721A when expressed alone. In these cell lines, 
EGF-induced  receptor downregulation  plateaued at higher 
levels of surface binding as compared with downregulation 
of wt or CD63  alone. 
We followed the fate of the two receptor species expressed 
in the same cells with methods able to distinguish between 
these two mutants.  Analysis of receptor degradation in re- 
sponse to EGF stimulation indicated  that the two types of 
receptor retained their particular behavior even when coex- 
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the  half-life  of  the  kinase-negative  mutant,  nor  was  the 
degradation rate of CD63 receptor slowed down by the pres- 
ence of the K721A mutant receptor. Since coimmunoprecipi- 
tation, cross-phosphorylation (12),  and covalent cross-link- 
ing experiments all  indicated  that the mutants are able to 
form mixed oligomers,  it  is  unlikely that the two mutants 
receptors use different pathways of internalization. The two 
receptor types encounter each other at least when embedded 
in the plasma membrane. However, at some later stage in the 
endocytic pathway,  the two receptor mutants clearly follow 
separate destinies. The mechanism that governs the itinerary 
of the two mutant receptors must operate at the molecular 
level as it distinguishes between receptor molecules accord- 
ing to their intrinsic  kinase activities.  The most plausible 
mechanism is that during endocytosis, the activated recep- 
tors phosphorylate a "sorting substrate(s)" which directs the 
activated receptors toward a degradation pathway. The kinase 
negative mutant that cannot phosphorylate the sorting sub- 
strate is delivered back to the cell surface by a constitutive 
recycling mechanism. In other words, the kinase activity pre- 
vents the return of EGFR to the cell surface by constitutive 
recycling mechanism, which is used by receptors lacking ty- 
rosine kinase activity  such as LDL  receptor or transferrin 
receptor (5). 
Received for publication 10 October 1989 and in revised form 22 January 
1990. 
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